This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish

On February 17, 2026, Superstring Capital Management reported selling 345,869 shares of Terns Pharmaceuticals (NASDAQ:TERN) ...

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?

This clinical-stage biotech develops therapies for NASH and obesity, advancing a pipeline of proprietary small-molecule drug ...

Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree

Novartis AG faces major patent expiries but is buying pipeline assets to sustain growth. Click for this NVS update.
RSVP Live on MSN

Brave cancer survivors open up about their symptoms and why it's important to stay positive

To mark Daffodil Day, we chat to two cancer survivors to learn what living with cancer is like - they say it's important to ...
Science Daily

Treating chronic inflammatory diseases with JAK inhibitors

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...

Teenager Diagnosed With Leukaemia After Doctors 'Dismissed' Symptoms; Know The Signs, Types And Risks

Leukaemia is cancer of the blood-forming tissue, including the bone marrow and the lymphatic system. It is characterised by ...